nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0569	0.0703	CbGbCtD
Rosuvastatin—ABCB11—Cyclosporine—psoriasis	0.042	0.0519	CbGbCtD
Rosuvastatin—ALB—Acitretin—psoriasis	0.0388	0.0479	CbGbCtD
Rosuvastatin—CYP3A5—Beclomethasone—psoriasis	0.0367	0.0453	CbGbCtD
Rosuvastatin—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0332	0.0409	CbGbCtD
Rosuvastatin—ABCC1—Cyclosporine—psoriasis	0.0298	0.0368	CbGbCtD
Rosuvastatin—SLCO1A2—Prednisolone—psoriasis	0.0298	0.0367	CbGbCtD
Rosuvastatin—SLCO1A2—Hydrocortisone—psoriasis	0.0282	0.0348	CbGbCtD
Rosuvastatin—SLCO1A2—Prednisone—psoriasis	0.0281	0.0347	CbGbCtD
Rosuvastatin—ABCB11—Dexamethasone—psoriasis	0.0277	0.0341	CbGbCtD
Rosuvastatin—SLCO1A2—Cyclosporine—psoriasis	0.0266	0.0329	CbGbCtD
Rosuvastatin—ABCG2—Mycophenolate mofetil—psoriasis	0.0263	0.0325	CbGbCtD
Rosuvastatin—SLCO1B1—Cyclosporine—psoriasis	0.0251	0.031	CbGbCtD
Rosuvastatin—SLCO1B3—Methotrexate—psoriasis	0.0228	0.0282	CbGbCtD
Rosuvastatin—ABCG2—Hydrocortisone—psoriasis	0.0211	0.0261	CbGbCtD
Rosuvastatin—ABCG2—Cyclosporine—psoriasis	0.02	0.0246	CbGbCtD
Rosuvastatin—ABCC4—Methotrexate—psoriasis	0.0196	0.0243	CbGbCtD
Rosuvastatin—ALB—Mycophenolate mofetil—psoriasis	0.0182	0.0224	CbGbCtD
Rosuvastatin—SLCO1A2—Dexamethasone—psoriasis	0.0175	0.0217	CbGbCtD
Rosuvastatin—ABCC1—Methotrexate—psoriasis	0.0158	0.0195	CbGbCtD
Rosuvastatin—CYP3A5—Mycophenolate mofetil—psoriasis	0.0146	0.018	CbGbCtD
Rosuvastatin—ALB—Prednisone—psoriasis	0.0145	0.0179	CbGbCtD
Rosuvastatin—SLCO1A2—Methotrexate—psoriasis	0.0141	0.0174	CbGbCtD
Rosuvastatin—CYP2C19—Cholecalciferol—psoriasis	0.0136	0.0168	CbGbCtD
Rosuvastatin—SLCO1B1—Methotrexate—psoriasis	0.0133	0.0164	CbGbCtD
Rosuvastatin—ABCG2—Dexamethasone—psoriasis	0.0131	0.0162	CbGbCtD
Rosuvastatin—CYP3A4—Calcitriol—psoriasis	0.0127	0.0157	CbGbCtD
Rosuvastatin—CYP3A5—Hydrocortisone—psoriasis	0.0117	0.0145	CbGbCtD
Rosuvastatin—CYP2C9—Cholecalciferol—psoriasis	0.0113	0.0139	CbGbCtD
Rosuvastatin—CYP3A5—Cyclosporine—psoriasis	0.0111	0.0137	CbGbCtD
Rosuvastatin—ABCG2—Methotrexate—psoriasis	0.0106	0.013	CbGbCtD
Rosuvastatin—CYP3A4—Methoxsalen—psoriasis	0.00991	0.0122	CbGbCtD
Rosuvastatin—CYP2C19—Prednisone—psoriasis	0.00941	0.0116	CbGbCtD
Rosuvastatin—CYP2C19—Cyclosporine—psoriasis	0.00892	0.011	CbGbCtD
Rosuvastatin—CYP2C9—Cyclosporine—psoriasis	0.00742	0.00916	CbGbCtD
Rosuvastatin—CYP3A5—Dexamethasone—psoriasis	0.00728	0.00899	CbGbCtD
Rosuvastatin—ALB—Methotrexate—psoriasis	0.00728	0.00899	CbGbCtD
Rosuvastatin—CYP3A4—Cholecalciferol—psoriasis	0.00656	0.0081	CbGbCtD
Rosuvastatin—CYP2C19—Dexamethasone—psoriasis	0.00588	0.00725	CbGbCtD
Rosuvastatin—CYP3A4—Mycophenolate mofetil—psoriasis	0.00569	0.00703	CbGbCtD
Rosuvastatin—CYP3A4—Triamcinolone—psoriasis	0.00569	0.00703	CbGbCtD
Rosuvastatin—CYP2C9—Dexamethasone—psoriasis	0.00488	0.00603	CbGbCtD
Rosuvastatin—CYP3A4—Betamethasone—psoriasis	0.00488	0.00603	CbGbCtD
Rosuvastatin—CYP3A4—Prednisolone—psoriasis	0.00482	0.00595	CbGbCtD
Rosuvastatin—CYP3A4—Hydrocortisone—psoriasis	0.00457	0.00564	CbGbCtD
Rosuvastatin—CYP3A4—Prednisone—psoriasis	0.00455	0.00562	CbGbCtD
Rosuvastatin—CYP3A4—Cyclosporine—psoriasis	0.00431	0.00533	CbGbCtD
Rosuvastatin—CYP3A4—Dexamethasone—psoriasis	0.00284	0.00351	CbGbCtD
Rosuvastatin—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000763	0.043	CbGpPWpGaD
Rosuvastatin—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000695	0.0392	CbGpPWpGaD
Rosuvastatin—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000611	0.0345	CbGpPWpGaD
Rosuvastatin—HMGCR—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.000501	0.0283	CbGpPWpGaD
Rosuvastatin—SLC7A11—Dexamethasone—Clobetasol propionate—psoriasis	0.000486	0.0968	CbGdCrCtD
Rosuvastatin—SLC7A11—Betamethasone—Clobetasol propionate—psoriasis	0.000486	0.0968	CbGdCrCtD
Rosuvastatin—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000473	0.0267	CbGpPWpGaD
Rosuvastatin—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000431	0.0243	CbGpPWpGaD
Rosuvastatin—ABCB11—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000429	0.0242	CbGpPWpGaD
Rosuvastatin—HMGCR—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.0004	0.0226	CbGpPWpGaD
Rosuvastatin—SLC7A11—Betamethasone—Beclomethasone—psoriasis	0.00039	0.0776	CbGdCrCtD
Rosuvastatin—SLC7A11—Betamethasone—Fluocinonide—psoriasis	0.00039	0.0776	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Beclomethasone—psoriasis	0.00039	0.0776	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Fluocinonide—psoriasis	0.00039	0.0776	CbGdCrCtD
Rosuvastatin—ABCC4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000386	0.0218	CbGpPWpGaD
Rosuvastatin—SLC7A11—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000379	0.0754	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000379	0.0754	CbGdCrCtD
Rosuvastatin—SLC7A11—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000347	0.0196	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—SERPINB8—psoriasis	0.000324	0.0183	CbGpPWpGaD
Rosuvastatin—HMGCR—Statin Pathway—APOE—psoriasis	0.00031	0.0175	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000306	0.0173	CbGpPWpGaD
Rosuvastatin—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000284	0.016	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000269	0.0152	CbGpPWpGaD
Rosuvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000254	0.0143	CbGpPWpGaD
Rosuvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000251	0.0141	CbGpPWpGaD
Rosuvastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000246	0.0139	CbGpPWpGaD
Rosuvastatin—ABCG2—Iron uptake and transport—CP—psoriasis	0.000237	0.0134	CbGpPWpGaD
Rosuvastatin—SLC7A11—NRF2 pathway—TGFA—psoriasis	0.000235	0.0132	CbGpPWpGaD
Rosuvastatin—HMGCR—PPARA activates gene expression—CARM1—psoriasis	0.000223	0.0126	CbGpPWpGaD
Rosuvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	0.000218	0.0123	CbGpPWpGaD
Rosuvastatin—Headache—Acitretin—psoriasis	0.000218	0.0013	CcSEcCtD
Rosuvastatin—Headache—Fluocinolone Acetonide—psoriasis	0.000217	0.0013	CcSEcCtD
Rosuvastatin—Pharyngitis—Triamcinolone—psoriasis	0.000216	0.00129	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Betamethasone—psoriasis	0.000216	0.00129	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Dexamethasone—psoriasis	0.000216	0.00129	CcSEcCtD
Rosuvastatin—Arrhythmia—Prednisolone—psoriasis	0.000212	0.00127	CcSEcCtD
Rosuvastatin—Pancreatitis—Prednisone—psoriasis	0.000211	0.00126	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000209	0.00125	CcSEcCtD
Rosuvastatin—Angioedema—Cyclosporine—psoriasis	0.000207	0.00124	CcSEcCtD
Rosuvastatin—Insomnia—Mycophenolic acid—psoriasis	0.000207	0.00124	CcSEcCtD
Rosuvastatin—Arrhythmia—Hydrocortisone—psoriasis	0.000207	0.00124	CcSEcCtD
Rosuvastatin—Nausea—Acitretin—psoriasis	0.000207	0.00124	CcSEcCtD
Rosuvastatin—Nausea—Fluocinolone Acetonide—psoriasis	0.000206	0.00123	CcSEcCtD
Rosuvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000206	0.0116	CbGpPWpGaD
Rosuvastatin—Paraesthesia—Mycophenolic acid—psoriasis	0.000206	0.00123	CcSEcCtD
Rosuvastatin—Mental disorder—Hydrocortisone—psoriasis	0.000203	0.00121	CcSEcCtD
Rosuvastatin—Angioedema—Mycophenolate mofetil—psoriasis	0.000202	0.00121	CcSEcCtD
Rosuvastatin—Dyspepsia—Mycophenolic acid—psoriasis	0.000201	0.0012	CcSEcCtD
Rosuvastatin—Hypersensitivity—Hydroxyurea—psoriasis	0.000201	0.0012	CcSEcCtD
Rosuvastatin—Cough—Cyclosporine—psoriasis	0.000198	0.00118	CcSEcCtD
Rosuvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000196	0.0111	CbGpPWpGaD
Rosuvastatin—Asthenia—Hydroxyurea—psoriasis	0.000196	0.00117	CcSEcCtD
Rosuvastatin—Constipation—Mycophenolic acid—psoriasis	0.000196	0.00117	CcSEcCtD
Rosuvastatin—Pain—Mycophenolic acid—psoriasis	0.000196	0.00117	CcSEcCtD
Rosuvastatin—Arrhythmia—Triamcinolone—psoriasis	0.000195	0.00116	CcSEcCtD
Rosuvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000194	0.0109	CbGpPWpGaD
Rosuvastatin—Myalgia—Cyclosporine—psoriasis	0.000193	0.00115	CcSEcCtD
Rosuvastatin—Arthralgia—Cyclosporine—psoriasis	0.000193	0.00115	CcSEcCtD
Rosuvastatin—Cough—Mycophenolate mofetil—psoriasis	0.000193	0.00115	CcSEcCtD
Rosuvastatin—Depression—Prednisone—psoriasis	0.000191	0.00114	CcSEcCtD
Rosuvastatin—SLC7A11—Betamethasone—Hydrocortisone—psoriasis	0.000191	0.0381	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Hydrocortisone—psoriasis	0.000191	0.0381	CbGdCrCtD
Rosuvastatin—Angioedema—Prednisolone—psoriasis	0.000189	0.00113	CcSEcCtD
Rosuvastatin—Feeling abnormal—Mycophenolic acid—psoriasis	0.000189	0.00113	CcSEcCtD
Rosuvastatin—Myalgia—Mycophenolate mofetil—psoriasis	0.000188	0.00113	CcSEcCtD
Rosuvastatin—Arthralgia—Mycophenolate mofetil—psoriasis	0.000188	0.00113	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Prednisone—psoriasis	0.000188	0.00112	CcSEcCtD
Rosuvastatin—Breast disorder—Methotrexate—psoriasis	0.000188	0.00112	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000187	0.00112	CcSEcCtD
Rosuvastatin—Diarrhoea—Hydroxyurea—psoriasis	0.000187	0.00112	CcSEcCtD
Rosuvastatin—Confusional state—Cyclosporine—psoriasis	0.000187	0.00112	CcSEcCtD
Rosuvastatin—Angioedema—Hydrocortisone—psoriasis	0.000184	0.0011	CcSEcCtD
Rosuvastatin—Infection—Cyclosporine—psoriasis	0.000184	0.0011	CcSEcCtD
Rosuvastatin—Confusional state—Mycophenolate mofetil—psoriasis	0.000182	0.00109	CcSEcCtD
Rosuvastatin—Nervous system disorder—Cyclosporine—psoriasis	0.000182	0.00109	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Cyclosporine—psoriasis	0.000181	0.00108	CcSEcCtD
Rosuvastatin—Abdominal pain—Mycophenolic acid—psoriasis	0.000181	0.00108	CcSEcCtD
Rosuvastatin—Dizziness—Hydroxyurea—psoriasis	0.000181	0.00108	CcSEcCtD
Rosuvastatin—Infection—Mycophenolate mofetil—psoriasis	0.000179	0.00107	CcSEcCtD
Rosuvastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000179	0.0101	CbGpPWpGaD
Rosuvastatin—SLC7A11—Dexamethasone—Betamethasone—psoriasis	0.000178	0.0353	CbGdCrCtD
Rosuvastatin—SLC7A11—Betamethasone—Dexamethasone—psoriasis	0.000178	0.0353	CbGdCrCtD
Rosuvastatin—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.000177	0.00106	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.000177	0.00106	CcSEcCtD
Rosuvastatin—Arrhythmia—Betamethasone—psoriasis	0.000177	0.00106	CcSEcCtD
Rosuvastatin—Arrhythmia—Dexamethasone—psoriasis	0.000177	0.00106	CcSEcCtD
Rosuvastatin—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000177	0.00997	CbGpPWpGaD
Rosuvastatin—Pancreatitis—Methotrexate—psoriasis	0.000176	0.00105	CcSEcCtD
Rosuvastatin—SLC7A11—Betamethasone—Triamcinolone—psoriasis	0.000174	0.0345	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Triamcinolone—psoriasis	0.000174	0.0345	CbGdCrCtD
Rosuvastatin—Angioedema—Triamcinolone—psoriasis	0.000173	0.00104	CcSEcCtD
Rosuvastatin—Rash—Hydroxyurea—psoriasis	0.000172	0.00103	CcSEcCtD
Rosuvastatin—Dermatitis—Hydroxyurea—psoriasis	0.000172	0.00103	CcSEcCtD
Rosuvastatin—Myalgia—Hydrocortisone—psoriasis	0.000172	0.00103	CcSEcCtD
Rosuvastatin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000172	0.00969	CbGpPWpGaD
Rosuvastatin—Headache—Hydroxyurea—psoriasis	0.000171	0.00102	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000169	0.00101	CcSEcCtD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	0.000168	0.00949	CbGpPWpGaD
Rosuvastatin—Insomnia—Cyclosporine—psoriasis	0.000167	0.001	CcSEcCtD
Rosuvastatin—Paraesthesia—Cyclosporine—psoriasis	0.000166	0.000994	CcSEcCtD
Rosuvastatin—Cough—Triamcinolone—psoriasis	0.000166	0.00099	CcSEcCtD
Rosuvastatin—SLC7A11—Betamethasone—Prednisone—psoriasis	0.000165	0.0328	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Prednisone—psoriasis	0.000165	0.0328	CbGdCrCtD
Rosuvastatin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000165	0.000984	CcSEcCtD
Rosuvastatin—Asthenia—Mycophenolic acid—psoriasis	0.000164	0.000982	CcSEcCtD
Rosuvastatin—Infection—Hydrocortisone—psoriasis	0.000163	0.000977	CcSEcCtD
Rosuvastatin—Insomnia—Mycophenolate mofetil—psoriasis	0.000163	0.000977	CcSEcCtD
Rosuvastatin—Dyspepsia—Cyclosporine—psoriasis	0.000163	0.000974	CcSEcCtD
Rosuvastatin—Nausea—Hydroxyurea—psoriasis	0.000162	0.00097	CcSEcCtD
Rosuvastatin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000162	0.00097	CcSEcCtD
Rosuvastatin—Pruritus—Mycophenolic acid—psoriasis	0.000162	0.000968	CcSEcCtD
Rosuvastatin—Myalgia—Triamcinolone—psoriasis	0.000162	0.000966	CcSEcCtD
Rosuvastatin—Nervous system disorder—Hydrocortisone—psoriasis	0.000161	0.000965	CcSEcCtD
Rosuvastatin—SLC7A11—Betamethasone—Prednisolone—psoriasis	0.000161	0.032	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Prednisolone—psoriasis	0.000161	0.032	CbGdCrCtD
Rosuvastatin—ABCC4—Hemostasis—SERPINB8—psoriasis	0.00016	0.00904	CbGpPWpGaD
Rosuvastatin—Depression—Methotrexate—psoriasis	0.00016	0.000956	CcSEcCtD
Rosuvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000159	0.00898	CbGpPWpGaD
Rosuvastatin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000159	0.00095	CcSEcCtD
Rosuvastatin—Constipation—Cyclosporine—psoriasis	0.000158	0.000947	CcSEcCtD
Rosuvastatin—Pain—Cyclosporine—psoriasis	0.000158	0.000947	CcSEcCtD
Rosuvastatin—Angioedema—Betamethasone—psoriasis	0.000157	0.000941	CcSEcCtD
Rosuvastatin—Angioedema—Dexamethasone—psoriasis	0.000157	0.000941	CcSEcCtD
Rosuvastatin—Diarrhoea—Mycophenolic acid—psoriasis	0.000157	0.000936	CcSEcCtD
Rosuvastatin—SLC7A11—SLC-mediated transmembrane transport—CP—psoriasis	0.000155	0.00875	CbGpPWpGaD
Rosuvastatin—HMGCR—AMPK Signaling—LEP—psoriasis	0.000155	0.00873	CbGpPWpGaD
Rosuvastatin—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000155	0.00873	CbGpPWpGaD
Rosuvastatin—Pain—Mycophenolate mofetil—psoriasis	0.000154	0.000923	CcSEcCtD
Rosuvastatin—Constipation—Mycophenolate mofetil—psoriasis	0.000154	0.000923	CcSEcCtD
Rosuvastatin—Arrhythmia—Prednisone—psoriasis	0.000154	0.00092	CcSEcCtD
Rosuvastatin—Infection—Triamcinolone—psoriasis	0.000154	0.00092	CcSEcCtD
Rosuvastatin—Haematuria—Methotrexate—psoriasis	0.000153	0.000914	CcSEcCtD
Rosuvastatin—Feeling abnormal—Cyclosporine—psoriasis	0.000153	0.000912	CcSEcCtD
Rosuvastatin—Insomnia—Prednisolone—psoriasis	0.000152	0.000911	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Methotrexate—psoriasis	0.000152	0.000907	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000151	0.000905	CcSEcCtD
Rosuvastatin—Dizziness—Mycophenolic acid—psoriasis	0.000151	0.000905	CcSEcCtD
Rosuvastatin—Paraesthesia—Prednisolone—psoriasis	0.000151	0.000904	CcSEcCtD
Rosuvastatin—Mental disorder—Prednisone—psoriasis	0.000151	0.000903	CcSEcCtD
Rosuvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	0.00015	0.00849	CbGpPWpGaD
Rosuvastatin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00015	0.000896	CcSEcCtD
Rosuvastatin—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000149	0.00089	CcSEcCtD
Rosuvastatin—Insomnia—Hydrocortisone—psoriasis	0.000149	0.00089	CcSEcCtD
Rosuvastatin—Paraesthesia—Hydrocortisone—psoriasis	0.000148	0.000883	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000148	0.000883	CcSEcCtD
Rosuvastatin—Urticaria—Cyclosporine—psoriasis	0.000147	0.000879	CcSEcCtD
Rosuvastatin—Myalgia—Betamethasone—psoriasis	0.000147	0.000877	CcSEcCtD
Rosuvastatin—Myalgia—Dexamethasone—psoriasis	0.000147	0.000877	CcSEcCtD
Rosuvastatin—Abdominal pain—Cyclosporine—psoriasis	0.000146	0.000875	CcSEcCtD
Rosuvastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000145	0.00819	CbGpPWpGaD
Rosuvastatin—Dyspepsia—Hydrocortisone—psoriasis	0.000145	0.000866	CcSEcCtD
Rosuvastatin—Rash—Mycophenolic acid—psoriasis	0.000144	0.000863	CcSEcCtD
Rosuvastatin—Dermatitis—Mycophenolic acid—psoriasis	0.000144	0.000862	CcSEcCtD
Rosuvastatin—Pain—Prednisolone—psoriasis	0.000144	0.000861	CcSEcCtD
Rosuvastatin—Hepatitis—Methotrexate—psoriasis	0.000144	0.000861	CcSEcCtD
Rosuvastatin—Urticaria—Mycophenolate mofetil—psoriasis	0.000144	0.000858	CcSEcCtD
Rosuvastatin—Headache—Mycophenolic acid—psoriasis	0.000143	0.000857	CcSEcCtD
Rosuvastatin—Pharyngitis—Methotrexate—psoriasis	0.000143	0.000855	CcSEcCtD
Rosuvastatin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000143	0.000854	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000141	0.000844	CcSEcCtD
Rosuvastatin—Pain—Hydrocortisone—psoriasis	0.000141	0.000841	CcSEcCtD
Rosuvastatin—Insomnia—Triamcinolone—psoriasis	0.00014	0.000838	CcSEcCtD
Rosuvastatin—Infection—Dexamethasone—psoriasis	0.00014	0.000835	CcSEcCtD
Rosuvastatin—Infection—Betamethasone—psoriasis	0.00014	0.000835	CcSEcCtD
Rosuvastatin—Paraesthesia—Triamcinolone—psoriasis	0.000139	0.000832	CcSEcCtD
Rosuvastatin—Feeling abnormal—Prednisolone—psoriasis	0.000139	0.00083	CcSEcCtD
Rosuvastatin—Nervous system disorder—Betamethasone—psoriasis	0.000138	0.000824	CcSEcCtD
Rosuvastatin—Nervous system disorder—Dexamethasone—psoriasis	0.000138	0.000824	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Dexamethasone—psoriasis	0.000138	0.000823	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Betamethasone—psoriasis	0.000138	0.000823	CcSEcCtD
Rosuvastatin—Angioedema—Prednisone—psoriasis	0.000137	0.000819	CcSEcCtD
Rosuvastatin—Hypersensitivity—Cyclosporine—psoriasis	0.000136	0.000815	CcSEcCtD
Rosuvastatin—Dyspepsia—Triamcinolone—psoriasis	0.000136	0.000815	CcSEcCtD
Rosuvastatin—Nausea—Mycophenolic acid—psoriasis	0.000136	0.000813	CcSEcCtD
Rosuvastatin—Feeling abnormal—Hydrocortisone—psoriasis	0.000136	0.000811	CcSEcCtD
Rosuvastatin—HMGCR—SREBP signalling—PPARG—psoriasis	0.000135	0.00761	CbGpPWpGaD
Rosuvastatin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000135	0.000804	CcSEcCtD
Rosuvastatin—Urticaria—Prednisolone—psoriasis	0.000134	0.0008	CcSEcCtD
Rosuvastatin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000133	0.000796	CcSEcCtD
Rosuvastatin—Asthenia—Cyclosporine—psoriasis	0.000133	0.000794	CcSEcCtD
Rosuvastatin—Pain—Triamcinolone—psoriasis	0.000133	0.000792	CcSEcCtD
Rosuvastatin—Pruritus—Cyclosporine—psoriasis	0.000131	0.000783	CcSEcCtD
Rosuvastatin—Urticaria—Hydrocortisone—psoriasis	0.000131	0.000781	CcSEcCtD
Rosuvastatin—Abdominal pain—Hydrocortisone—psoriasis	0.00013	0.000778	CcSEcCtD
Rosuvastatin—Asthenia—Mycophenolate mofetil—psoriasis	0.00013	0.000775	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000128	0.000766	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000128	0.000766	CcSEcCtD
Rosuvastatin—Pruritus—Mycophenolate mofetil—psoriasis	0.000128	0.000764	CcSEcCtD
Rosuvastatin—Myalgia—Prednisone—psoriasis	0.000128	0.000763	CcSEcCtD
Rosuvastatin—Arthralgia—Prednisone—psoriasis	0.000128	0.000763	CcSEcCtD
Rosuvastatin—Feeling abnormal—Triamcinolone—psoriasis	0.000128	0.000763	CcSEcCtD
Rosuvastatin—ABCC1—S1P1 pathway—VEGFA—psoriasis	0.000127	0.00718	CbGpPWpGaD
Rosuvastatin—Insomnia—Betamethasone—psoriasis	0.000127	0.00076	CcSEcCtD
Rosuvastatin—Insomnia—Dexamethasone—psoriasis	0.000127	0.00076	CcSEcCtD
Rosuvastatin—Diarrhoea—Cyclosporine—psoriasis	0.000127	0.000757	CcSEcCtD
Rosuvastatin—Paraesthesia—Dexamethasone—psoriasis	0.000126	0.000755	CcSEcCtD
Rosuvastatin—Paraesthesia—Betamethasone—psoriasis	0.000126	0.000755	CcSEcCtD
Rosuvastatin—Mental disorder—Methotrexate—psoriasis	0.000126	0.000754	CcSEcCtD
Rosuvastatin—Hypersensitivity—Prednisolone—psoriasis	0.000124	0.000742	CcSEcCtD
Rosuvastatin—Dyspepsia—Betamethasone—psoriasis	0.000124	0.00074	CcSEcCtD
Rosuvastatin—Dyspepsia—Dexamethasone—psoriasis	0.000124	0.00074	CcSEcCtD
Rosuvastatin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000124	0.000739	CcSEcCtD
Rosuvastatin—Urticaria—Triamcinolone—psoriasis	0.000123	0.000736	CcSEcCtD
Rosuvastatin—Dizziness—Cyclosporine—psoriasis	0.000122	0.000732	CcSEcCtD
Rosuvastatin—Infection—Prednisone—psoriasis	0.000122	0.000727	CcSEcCtD
Rosuvastatin—Hypersensitivity—Hydrocortisone—psoriasis	0.000121	0.000725	CcSEcCtD
Rosuvastatin—Pain—Dexamethasone—psoriasis	0.00012	0.000719	CcSEcCtD
Rosuvastatin—Pain—Betamethasone—psoriasis	0.00012	0.000719	CcSEcCtD
Rosuvastatin—Nervous system disorder—Prednisone—psoriasis	0.00012	0.000718	CcSEcCtD
Rosuvastatin—Dizziness—Mycophenolate mofetil—psoriasis	0.000119	0.000714	CcSEcCtD
Rosuvastatin—Asthenia—Hydrocortisone—psoriasis	0.000118	0.000706	CcSEcCtD
Rosuvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000118	0.00666	CbGpPWpGaD
Rosuvastatin—Rash—Cyclosporine—psoriasis	0.000117	0.000698	CcSEcCtD
Rosuvastatin—Dermatitis—Cyclosporine—psoriasis	0.000117	0.000697	CcSEcCtD
Rosuvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000116	0.00658	CbGpPWpGaD
Rosuvastatin—Pruritus—Hydrocortisone—psoriasis	0.000116	0.000696	CcSEcCtD
Rosuvastatin—Headache—Cyclosporine—psoriasis	0.000116	0.000693	CcSEcCtD
Rosuvastatin—Feeling abnormal—Dexamethasone—psoriasis	0.000116	0.000693	CcSEcCtD
Rosuvastatin—Feeling abnormal—Betamethasone—psoriasis	0.000116	0.000693	CcSEcCtD
Rosuvastatin—ABCC4—NRF2 pathway—TGFA—psoriasis	0.000116	0.00654	CbGpPWpGaD
Rosuvastatin—SLCO2B1—SLC-mediated transmembrane transport—CP—psoriasis	0.000116	0.00652	CbGpPWpGaD
Rosuvastatin—Gastrointestinal pain—Betamethasone—psoriasis	0.000115	0.000687	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000115	0.000687	CcSEcCtD
Rosuvastatin—Hypersensitivity—Triamcinolone—psoriasis	0.000114	0.000682	CcSEcCtD
Rosuvastatin—Rash—Mycophenolate mofetil—psoriasis	0.000114	0.000681	CcSEcCtD
Rosuvastatin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000114	0.00068	CcSEcCtD
Rosuvastatin—Headache—Mycophenolate mofetil—psoriasis	0.000113	0.000676	CcSEcCtD
Rosuvastatin—Diarrhoea—Hydrocortisone—psoriasis	0.000113	0.000673	CcSEcCtD
Rosuvastatin—Urticaria—Dexamethasone—psoriasis	0.000112	0.000668	CcSEcCtD
Rosuvastatin—Urticaria—Betamethasone—psoriasis	0.000112	0.000668	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000112	0.000667	CcSEcCtD
Rosuvastatin—Dizziness—Prednisolone—psoriasis	0.000111	0.000666	CcSEcCtD
Rosuvastatin—Asthenia—Triamcinolone—psoriasis	0.000111	0.000665	CcSEcCtD
Rosuvastatin—Abdominal pain—Betamethasone—psoriasis	0.000111	0.000664	CcSEcCtD
Rosuvastatin—Abdominal pain—Dexamethasone—psoriasis	0.000111	0.000664	CcSEcCtD
Rosuvastatin—Insomnia—Prednisone—psoriasis	0.000111	0.000662	CcSEcCtD
Rosuvastatin—Nausea—Cyclosporine—psoriasis	0.00011	0.000657	CcSEcCtD
Rosuvastatin—Paraesthesia—Prednisone—psoriasis	0.00011	0.000657	CcSEcCtD
Rosuvastatin—Pruritus—Triamcinolone—psoriasis	0.00011	0.000655	CcSEcCtD
Rosuvastatin—Cough—Methotrexate—psoriasis	0.000109	0.000654	CcSEcCtD
Rosuvastatin—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000109	0.00617	CbGpPWpGaD
Rosuvastatin—Dizziness—Hydrocortisone—psoriasis	0.000109	0.00065	CcSEcCtD
Rosuvastatin—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000108	0.00609	CbGpPWpGaD
Rosuvastatin—Dyspepsia—Prednisone—psoriasis	0.000108	0.000644	CcSEcCtD
Rosuvastatin—Nausea—Mycophenolate mofetil—psoriasis	0.000107	0.000641	CcSEcCtD
Rosuvastatin—Myalgia—Methotrexate—psoriasis	0.000107	0.000638	CcSEcCtD
Rosuvastatin—Arthralgia—Methotrexate—psoriasis	0.000107	0.000638	CcSEcCtD
Rosuvastatin—Rash—Prednisolone—psoriasis	0.000106	0.000635	CcSEcCtD
Rosuvastatin—Dermatitis—Prednisolone—psoriasis	0.000106	0.000634	CcSEcCtD
Rosuvastatin—Headache—Prednisolone—psoriasis	0.000106	0.000631	CcSEcCtD
Rosuvastatin—Constipation—Prednisone—psoriasis	0.000105	0.000626	CcSEcCtD
Rosuvastatin—Rash—Hydrocortisone—psoriasis	0.000104	0.00062	CcSEcCtD
Rosuvastatin—Dermatitis—Hydrocortisone—psoriasis	0.000104	0.00062	CcSEcCtD
Rosuvastatin—Confusional state—Methotrexate—psoriasis	0.000103	0.000617	CcSEcCtD
Rosuvastatin—Headache—Hydrocortisone—psoriasis	0.000103	0.000616	CcSEcCtD
Rosuvastatin—Dizziness—Triamcinolone—psoriasis	0.000102	0.000613	CcSEcCtD
Rosuvastatin—Infection—Methotrexate—psoriasis	0.000102	0.000608	CcSEcCtD
Rosuvastatin—Feeling abnormal—Prednisone—psoriasis	0.000101	0.000603	CcSEcCtD
Rosuvastatin—Asthenia—Betamethasone—psoriasis	0.000101	0.000603	CcSEcCtD
Rosuvastatin—Asthenia—Dexamethasone—psoriasis	0.000101	0.000603	CcSEcCtD
Rosuvastatin—Nervous system disorder—Methotrexate—psoriasis	0.0001	0.0006	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Methotrexate—psoriasis	0.0001	0.000599	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Prednisone—psoriasis	0.0001	0.000598	CcSEcCtD
Rosuvastatin—Nausea—Prednisolone—psoriasis	0.0001	0.000598	CcSEcCtD
Rosuvastatin—Pruritus—Betamethasone—psoriasis	9.95e-05	0.000595	CcSEcCtD
Rosuvastatin—Pruritus—Dexamethasone—psoriasis	9.95e-05	0.000595	CcSEcCtD
Rosuvastatin—Nausea—Hydrocortisone—psoriasis	9.78e-05	0.000584	CcSEcCtD
Rosuvastatin—Rash—Triamcinolone—psoriasis	9.77e-05	0.000584	CcSEcCtD
Rosuvastatin—Dermatitis—Triamcinolone—psoriasis	9.76e-05	0.000583	CcSEcCtD
Rosuvastatin—Urticaria—Prednisone—psoriasis	9.73e-05	0.000581	CcSEcCtD
Rosuvastatin—Headache—Triamcinolone—psoriasis	9.71e-05	0.00058	CcSEcCtD
Rosuvastatin—Abdominal pain—Prednisone—psoriasis	9.68e-05	0.000579	CcSEcCtD
Rosuvastatin—Diarrhoea—Betamethasone—psoriasis	9.62e-05	0.000575	CcSEcCtD
Rosuvastatin—Diarrhoea—Dexamethasone—psoriasis	9.62e-05	0.000575	CcSEcCtD
Rosuvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	9.57e-05	0.0054	CbGpPWpGaD
Rosuvastatin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.44e-05	0.00533	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—ITGAL—psoriasis	9.42e-05	0.00532	CbGpPWpGaD
Rosuvastatin—Musculoskeletal discomfort—Methotrexate—psoriasis	9.32e-05	0.000557	CcSEcCtD
Rosuvastatin—Dizziness—Betamethasone—psoriasis	9.3e-05	0.000556	CcSEcCtD
Rosuvastatin—Dizziness—Dexamethasone—psoriasis	9.3e-05	0.000556	CcSEcCtD
Rosuvastatin—HMGCR—PPARA activates gene expression—PPARG—psoriasis	9.28e-05	0.00524	CbGpPWpGaD
Rosuvastatin—Insomnia—Methotrexate—psoriasis	9.26e-05	0.000553	CcSEcCtD
Rosuvastatin—Nausea—Triamcinolone—psoriasis	9.2e-05	0.00055	CcSEcCtD
Rosuvastatin—Paraesthesia—Methotrexate—psoriasis	9.19e-05	0.000549	CcSEcCtD
Rosuvastatin—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	9.08e-05	0.00513	CbGpPWpGaD
Rosuvastatin—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	9.02e-05	0.00509	CbGpPWpGaD
Rosuvastatin—Hypersensitivity—Prednisone—psoriasis	9.02e-05	0.000539	CcSEcCtD
Rosuvastatin—Dyspepsia—Methotrexate—psoriasis	9.01e-05	0.000538	CcSEcCtD
Rosuvastatin—ALB—Lipoprotein metabolism—APOE—psoriasis	8.89e-05	0.00502	CbGpPWpGaD
Rosuvastatin—Rash—Dexamethasone—psoriasis	8.87e-05	0.00053	CcSEcCtD
Rosuvastatin—Rash—Betamethasone—psoriasis	8.87e-05	0.00053	CcSEcCtD
Rosuvastatin—Dermatitis—Betamethasone—psoriasis	8.86e-05	0.000529	CcSEcCtD
Rosuvastatin—Dermatitis—Dexamethasone—psoriasis	8.86e-05	0.000529	CcSEcCtD
Rosuvastatin—Headache—Dexamethasone—psoriasis	8.81e-05	0.000527	CcSEcCtD
Rosuvastatin—Headache—Betamethasone—psoriasis	8.81e-05	0.000527	CcSEcCtD
Rosuvastatin—Asthenia—Prednisone—psoriasis	8.79e-05	0.000525	CcSEcCtD
Rosuvastatin—Pain—Methotrexate—psoriasis	8.75e-05	0.000523	CcSEcCtD
Rosuvastatin—Pruritus—Prednisone—psoriasis	8.66e-05	0.000518	CcSEcCtD
Rosuvastatin—CYP2C19—Biological oxidations—CYP2S1—psoriasis	8.45e-05	0.00477	CbGpPWpGaD
Rosuvastatin—Feeling abnormal—Methotrexate—psoriasis	8.43e-05	0.000504	CcSEcCtD
Rosuvastatin—Diarrhoea—Prednisone—psoriasis	8.38e-05	0.000501	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Methotrexate—psoriasis	8.37e-05	0.0005	CcSEcCtD
Rosuvastatin—Nausea—Betamethasone—psoriasis	8.35e-05	0.000499	CcSEcCtD
Rosuvastatin—Nausea—Dexamethasone—psoriasis	8.35e-05	0.000499	CcSEcCtD
Rosuvastatin—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	8.34e-05	0.00471	CbGpPWpGaD
Rosuvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.22e-05	0.00464	CbGpPWpGaD
Rosuvastatin—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	8.2e-05	0.00463	CbGpPWpGaD
Rosuvastatin—Urticaria—Methotrexate—psoriasis	8.13e-05	0.000486	CcSEcCtD
Rosuvastatin—Dizziness—Prednisone—psoriasis	8.1e-05	0.000484	CcSEcCtD
Rosuvastatin—Abdominal pain—Methotrexate—psoriasis	8.09e-05	0.000484	CcSEcCtD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—CP—psoriasis	7.87e-05	0.00445	CbGpPWpGaD
Rosuvastatin—Rash—Prednisone—psoriasis	7.72e-05	0.000461	CcSEcCtD
Rosuvastatin—Dermatitis—Prednisone—psoriasis	7.71e-05	0.000461	CcSEcCtD
Rosuvastatin—CYP2C9—Biological oxidations—CYP2S1—psoriasis	7.71e-05	0.00435	CbGpPWpGaD
Rosuvastatin—Headache—Prednisone—psoriasis	7.67e-05	0.000459	CcSEcCtD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	7.66e-05	0.00433	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	7.6e-05	0.00429	CbGpPWpGaD
Rosuvastatin—Hypersensitivity—Methotrexate—psoriasis	7.54e-05	0.000451	CcSEcCtD
Rosuvastatin—SLC7A11—Transmembrane transport of small molecules—CARM1—psoriasis	7.51e-05	0.00424	CbGpPWpGaD
Rosuvastatin—ABCC4—Fluoropyrimidine Activity—TP53—psoriasis	7.42e-05	0.00419	CbGpPWpGaD
Rosuvastatin—Asthenia—Methotrexate—psoriasis	7.34e-05	0.000439	CcSEcCtD
Rosuvastatin—Nausea—Prednisone—psoriasis	7.27e-05	0.000435	CcSEcCtD
Rosuvastatin—ALB—Hemostasis—SERPINB8—psoriasis	7.25e-05	0.00409	CbGpPWpGaD
Rosuvastatin—Pruritus—Methotrexate—psoriasis	7.24e-05	0.000433	CcSEcCtD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	7.14e-05	0.00403	CbGpPWpGaD
Rosuvastatin—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	7.09e-05	0.004	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	7.03e-05	0.00397	CbGpPWpGaD
Rosuvastatin—Diarrhoea—Methotrexate—psoriasis	7e-05	0.000419	CcSEcCtD
Rosuvastatin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	6.92e-05	0.00391	CbGpPWpGaD
Rosuvastatin—Dizziness—Methotrexate—psoriasis	6.77e-05	0.000404	CcSEcCtD
Rosuvastatin—Rash—Methotrexate—psoriasis	6.45e-05	0.000386	CcSEcCtD
Rosuvastatin—Dermatitis—Methotrexate—psoriasis	6.45e-05	0.000385	CcSEcCtD
Rosuvastatin—HMGCR—Metabolism—NDUFA5—psoriasis	6.42e-05	0.00362	CbGpPWpGaD
Rosuvastatin—Headache—Methotrexate—psoriasis	6.41e-05	0.000383	CcSEcCtD
Rosuvastatin—HMGCR—AMPK Signaling—TP53—psoriasis	6.31e-05	0.00356	CbGpPWpGaD
Rosuvastatin—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	6.26e-05	0.00353	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—CAT—psoriasis	6.09e-05	0.00344	CbGpPWpGaD
Rosuvastatin—Nausea—Methotrexate—psoriasis	6.08e-05	0.000363	CcSEcCtD
Rosuvastatin—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	6.06e-05	0.00342	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.99e-05	0.00338	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—CRP—psoriasis	5.94e-05	0.00335	CbGpPWpGaD
Rosuvastatin—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	5.9e-05	0.00333	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—CP—psoriasis	5.87e-05	0.00331	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—APOE—psoriasis	5.81e-05	0.00328	CbGpPWpGaD
Rosuvastatin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.73e-05	0.00324	CbGpPWpGaD
Rosuvastatin—SLCO2B1—Transmembrane transport of small molecules—CARM1—psoriasis	5.6e-05	0.00316	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—IL4—psoriasis	5.59e-05	0.00316	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CYP2S1—psoriasis	5.46e-05	0.00308	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	5.46e-05	0.00308	CbGpPWpGaD
Rosuvastatin—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	5.44e-05	0.00307	CbGpPWpGaD
Rosuvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.42e-05	0.00306	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—JUN—psoriasis	5.11e-05	0.00288	CbGpPWpGaD
Rosuvastatin—CYP3A4—Biological oxidations—CYP2S1—psoriasis	5.08e-05	0.00287	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	5.01e-05	0.00283	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—NDUFA5—psoriasis	4.93e-05	0.00278	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	4.92e-05	0.00278	CbGpPWpGaD
Rosuvastatin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	4.87e-05	0.00275	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet degranulation—VEGFA—psoriasis	4.84e-05	0.00273	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—CAT—psoriasis	4.83e-05	0.00273	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—CRP—psoriasis	4.83e-05	0.00273	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	4.73e-05	0.00267	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—ITGAL—psoriasis	4.65e-05	0.00263	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—NDUFA5—psoriasis	4.64e-05	0.00262	CbGpPWpGaD
Rosuvastatin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	4.61e-05	0.0026	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.6e-05	0.0026	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	4.58e-05	0.00259	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.46e-05	0.00252	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—ICAM1—psoriasis	4.44e-05	0.00251	CbGpPWpGaD
Rosuvastatin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	4.39e-05	0.00248	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	4.37e-05	0.00247	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.33e-05	0.00244	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CYP2S1—psoriasis	4.19e-05	0.00237	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	4.15e-05	0.00234	CbGpPWpGaD
Rosuvastatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	4.14e-05	0.00233	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CYP2S1—psoriasis	3.95e-05	0.00223	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—CP—psoriasis	3.89e-05	0.0022	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—NDUFA5—psoriasis	3.88e-05	0.00219	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—NOS2—psoriasis	3.86e-05	0.00218	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—CRP—psoriasis	3.84e-05	0.00217	CbGpPWpGaD
Rosuvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.78e-05	0.00213	CbGpPWpGaD
Rosuvastatin—ABCC4—Transmembrane transport of small molecules—CARM1—psoriasis	3.71e-05	0.00209	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.61e-05	0.00204	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	3.6e-05	0.00203	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	3.53e-05	0.00199	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—NDUFA5—psoriasis	3.49e-05	0.00197	CbGpPWpGaD
Rosuvastatin—ALB—SLC-mediated transmembrane transport—CP—psoriasis	3.46e-05	0.00195	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	3.46e-05	0.00195	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	3.44e-05	0.00194	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—IFNG—psoriasis	3.38e-05	0.00191	CbGpPWpGaD
Rosuvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—psoriasis	3.37e-05	0.0019	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—NDUFA5—psoriasis	3.31e-05	0.00187	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CYP2S1—psoriasis	3.3e-05	0.00186	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.25e-05	0.00184	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—CP—psoriasis	3.24e-05	0.00183	CbGpPWpGaD
Rosuvastatin—ABCC1—Transmembrane transport of small molecules—CARM1—psoriasis	3.09e-05	0.00175	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.09e-05	0.00174	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	3.08e-05	0.00174	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—NDUFA5—psoriasis	3.07e-05	0.00173	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CYP2S1—psoriasis	2.97e-05	0.00167	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	2.94e-05	0.00166	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.86e-05	0.00162	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	2.85e-05	0.00161	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CYP2S1—psoriasis	2.82e-05	0.00159	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—NFKB1—psoriasis	2.81e-05	0.00159	CbGpPWpGaD
Rosuvastatin—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	2.72e-05	0.00154	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—TNF—psoriasis	2.69e-05	0.00152	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—IFNG—psoriasis	2.68e-05	0.00152	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CARM1—psoriasis	2.67e-05	0.00151	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CYP2S1—psoriasis	2.61e-05	0.00147	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.49e-05	0.00141	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—VEGFA—psoriasis	2.24e-05	0.00126	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	2.23e-05	0.00126	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—NDUFA5—psoriasis	2.2e-05	0.00124	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.2e-05	0.00124	CbGpPWpGaD
Rosuvastatin—ALB—Platelet degranulation—VEGFA—psoriasis	2.19e-05	0.00124	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TNF—psoriasis	2.19e-05	0.00123	CbGpPWpGaD
Rosuvastatin—ALB—Vitamin B12 Metabolism—IL6—psoriasis	2.17e-05	0.00122	CbGpPWpGaD
Rosuvastatin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.14e-05	0.00121	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—ITGAL—psoriasis	2.11e-05	0.00119	CbGpPWpGaD
Rosuvastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	2.08e-05	0.00118	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.07e-05	0.00117	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CARM1—psoriasis	2.05e-05	0.00116	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—TP53—psoriasis	1.93e-05	0.00109	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CARM1—psoriasis	1.93e-05	0.00109	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.91e-05	0.00108	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—NOS2—psoriasis	1.91e-05	0.00108	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—NDUFA5—psoriasis	1.89e-05	0.00107	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CYP2S1—psoriasis	1.87e-05	0.00106	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.8e-05	0.00102	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.77e-05	0.000997	CbGpPWpGaD
Rosuvastatin—ALB—Folate Metabolism—IL6—psoriasis	1.77e-05	0.000996	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—CP—psoriasis	1.76e-05	0.000993	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—TNF—psoriasis	1.74e-05	0.000981	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.000975	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—NDUFA5—psoriasis	1.7e-05	0.00096	CbGpPWpGaD
Rosuvastatin—SLC7A11—Hemostasis—TP53—psoriasis	1.69e-05	0.000955	CbGpPWpGaD
Rosuvastatin—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	1.68e-05	0.000948	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—CAT—psoriasis	1.64e-05	0.000926	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CYP2S1—psoriasis	1.61e-05	0.000909	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CARM1—psoriasis	1.61e-05	0.000908	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.59e-05	0.000895	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.55e-05	0.000877	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—NDUFA5—psoriasis	1.55e-05	0.000875	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.5e-05	0.000849	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.48e-05	0.000834	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CARM1—psoriasis	1.45e-05	0.000818	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CYP2S1—psoriasis	1.45e-05	0.000816	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.45e-05	0.000816	CbGpPWpGaD
Rosuvastatin—ALB—Selenium Micronutrient Network—IL6—psoriasis	1.4e-05	0.000792	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CARM1—psoriasis	1.38e-05	0.000777	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.35e-05	0.000764	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CYP2S1—psoriasis	1.32e-05	0.000744	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.29e-05	0.000726	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CARM1—psoriasis	1.27e-05	0.000719	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—APOE—psoriasis	1.27e-05	0.000719	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—CAT—psoriasis	1.26e-05	0.000711	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—CAT—psoriasis	1.19e-05	0.000669	CbGpPWpGaD
Rosuvastatin—HMGCR—Metabolism—PPARG—psoriasis	1.11e-05	0.000627	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—VEGFA—psoriasis	1.11e-05	0.000624	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—NDUFA5—psoriasis	1.02e-05	0.000577	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—CAT—psoriasis	9.9e-06	0.000559	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—APOE—psoriasis	9.79e-06	0.000553	CbGpPWpGaD
Rosuvastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	9.71e-06	0.000548	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—APOE—psoriasis	9.21e-06	0.00052	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CARM1—psoriasis	9.13e-06	0.000515	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—CAT—psoriasis	8.91e-06	0.000503	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—HLA-A—psoriasis	8.85e-06	0.0005	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CYP2S1—psoriasis	8.69e-06	0.000491	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—NOS2—psoriasis	8.64e-06	0.000488	CbGpPWpGaD
Rosuvastatin—SLCO1B3—Metabolism—PPARG—psoriasis	8.53e-06	0.000481	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—CAT—psoriasis	8.47e-06	0.000478	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.44e-06	0.000476	CbGpPWpGaD
Rosuvastatin—ABCC4—Hemostasis—TP53—psoriasis	8.35e-06	0.000472	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—APOE—psoriasis	8.26e-06	0.000467	CbGpPWpGaD
Rosuvastatin—ABCB11—Metabolism—PPARG—psoriasis	8.03e-06	0.000453	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CARM1—psoriasis	7.86e-06	0.000444	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—CAT—psoriasis	7.84e-06	0.000442	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—NOS2—psoriasis	7.7e-06	0.000435	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—APOE—psoriasis	7.69e-06	0.000434	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.58e-06	0.000428	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.35e-06	0.000415	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CARM1—psoriasis	7.06e-06	0.000398	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—APOE—psoriasis	6.92e-06	0.000391	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.91e-06	0.00039	CbGpPWpGaD
Rosuvastatin—SLCO1A2—Metabolism—PPARG—psoriasis	6.7e-06	0.000378	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.6e-06	0.000372	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—APOE—psoriasis	6.58e-06	0.000371	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CARM1—psoriasis	6.44e-06	0.000363	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—TYK2—psoriasis	6.31e-06	0.000356	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—APOE—psoriasis	6.09e-06	0.000344	CbGpPWpGaD
Rosuvastatin—ABCC1—Metabolism—PPARG—psoriasis	6.03e-06	0.00034	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.02e-06	0.00034	CbGpPWpGaD
Rosuvastatin—SLCO1B1—Metabolism—PPARG—psoriasis	5.73e-06	0.000323	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—CD4—psoriasis	5.7e-06	0.000322	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—CAT—psoriasis	5.62e-06	0.000317	CbGpPWpGaD
Rosuvastatin—ABCG2—Metabolism—PPARG—psoriasis	5.31e-06	0.000299	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—VEGFA—psoriasis	5e-06	0.000282	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—CAT—psoriasis	4.84e-06	0.000273	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—STAT3—psoriasis	4.42e-06	0.000249	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—APOE—psoriasis	4.36e-06	0.000246	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—CAT—psoriasis	4.34e-06	0.000245	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CARM1—psoriasis	4.25e-06	0.00024	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—CAT—psoriasis	3.96e-06	0.000223	CbGpPWpGaD
Rosuvastatin—CYP3A5—Metabolism—PPARG—psoriasis	3.8e-06	0.000215	CbGpPWpGaD
Rosuvastatin—ALB—Hemostasis—TP53—psoriasis	3.78e-06	0.000213	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—APOE—psoriasis	3.76e-06	0.000212	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—APOE—psoriasis	3.37e-06	0.00019	CbGpPWpGaD
Rosuvastatin—ALB—Metabolism—PPARG—psoriasis	3.27e-06	0.000185	CbGpPWpGaD
Rosuvastatin—ABCC1—Disease—IL6—psoriasis	3.09e-06	0.000174	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—APOE—psoriasis	3.08e-06	0.000174	CbGpPWpGaD
Rosuvastatin—CYP2C19—Metabolism—PPARG—psoriasis	2.94e-06	0.000166	CbGpPWpGaD
Rosuvastatin—CYP2C9—Metabolism—PPARG—psoriasis	2.68e-06	0.000151	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—CAT—psoriasis	2.61e-06	0.000147	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—APOE—psoriasis	2.03e-06	0.000115	CbGpPWpGaD
Rosuvastatin—CYP3A4—Metabolism—PPARG—psoriasis	1.77e-06	9.97e-05	CbGpPWpGaD
